18F-Flutemetamol (Vizamyl™)
18F-Flutemetamol is a radioactive diagnostic agent used in positron emission tomography (PET) imaging of the brain to detect the presence of beta-amyloid plaques, which are… Read More »18F-Flutemetamol (Vizamyl™)
Home »
Alzheimer’s disease
Radiotracers in Imaging of Alzheimer’s Disease
Alzheimer’s disease (AD) is the most relevant form of dementia and an early and accurate diagnosis is not possible by clinical symptoms. Only at a… Read More »Radiotracers in Imaging of Alzheimer’s Disease
18F-Florbetapir (Amyvid®)
18F-Florbetapir, also known by the brand name Amyvid®, is a radiopharmaceutical used in positron emission tomography (PET) imaging for the detection of beta-amyloid plaques in… Read More »18F-Florbetapir (Amyvid®)
18F-Florbetaben (NeuraCeq™)
18F-Florbetaben, marketed under the brand name Neuraceq®, is a radiopharmaceutical used in positron emission tomography (PET) imaging for the detection of beta-amyloid plaques in the… Read More »18F-Florbetaben (NeuraCeq™)
18F-Flortaucipir (18F-AV-1451 – 18F-T807)
18F-Flortaucipir, also known as 18F-AV-1451 or T807, is a radiopharmaceutical used in positron emission tomography (PET) imaging for the detection of abnormal tau protein aggregates… Read More »18F-Flortaucipir (18F-AV-1451 – 18F-T807)
18F-Florapronol (Alzavue®)
Description 18F-Florapronol (18F-FC119S, Alzavue Injection®, 18F-2-[2-(N-monomethyl)-aminopyridine-6-yl]-6-[(S)-3-fluoro-2-hydroxypropoxy]-benzothiazole) is a radiolabeled tracer developed by FutureChem, which obtained its marketing authorization in South Korea in February 2018. This… Read More »18F-Florapronol (Alzavue®)